bring window of opportunity that it can bring about and it is an ongoing process bring about and it is an ongoing process where they require support and people i have worked with would argue and people i have worked with would argue for and people i have worked with would argue for the need for repeat dose, one session argue for the need for repeat dose, one session is not going to be sufficient, so for someone with depression who has suffered for many year. depression who has suffered for many year. they depression who has suffered for many year, they have one session, they depression year, they have one session, they depression usually tends to go away for a few depression usually tends to go away for a few months, slowly starts to return for a few months, slowly starts to return because often they are returning return because often they are returning to conditions, societal condition returning to conditions, societal condition that distributed to the c
about the. it would be frankly insane if it was, because why . about the. it would be frankly - insane if it was, because why people are so excited by the prospect of opening up mental health treatment, assisted by psychedelic psychotherapy is it offers hope to the, over one million people in the uk who suffer depression, who at the moment have no reasonable hope of a cure, they can have ssri prescribed which is a howl cure, they can have ssri prescribed which is a how i would describe as a chemical cosh to deal with the symptoms the and problems with people becoming addicted to those, to those treatments but they don t enable the therapies to have a reasonable shot at addressing the issue that is leading from the trauma or depression or anxiety, or indeed the addiction, these are conditions that affect a very large number of fellow citizens and why we need to get the regulatory place, as fast as we can, is to get the research, so we can get into a place with we can assess how we addre